The ferret: A cytotoxic drug-induced emesis model

Biogenic Amines

Volumn 18, Issue 3-6, 2004, Pages 419-434

  Endo, T ^a   Minami, M ^a   Hirafuji, M ^a   Hamaue, N ^a   Parvez, S H ^b  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b CNRS   (France)

Author keywords

5 HT; Cisplatin; EC cells; Ferret; Vagus afferent

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMINO ACID DECARBOXYLASE; ANTIEMETIC AGENT; CISPLATIN; COPPER SULFATE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; ONDANSETRON; SEROTONIN; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA POSTREMA; ARTICLE; BODY WEIGHT; CARNIVORE; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; DISEASE MODEL; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; ENTEROCHROMAFFIN CELL; ENZYME ACTIVITY; FERRET; ILEUM; INTERMETHOD COMPARISON; INTESTINE MUCOSA; MALE; NERVE CONDUCTION; NONHUMAN; PATHOPHYSIOLOGY; RECEPTOR UPREGULATION; SENSORY NERVE; SEROTONIN RELEASE; TREATMENT OUTCOME; VAGOTOMY; VAGUS NERVE STIMULATION;

ANIMALIA; EMESIS; MUSTELA; MUSTELA PUTORIUS FURO;

EID: 4344686683     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: 10.1163/1569391041501834     Document Type: Article

References (70)

1. Albuquerque, E. C., Pereira, E. F, Castro, N. G., et al. (1995). Nicotinic receptor function in the mammalian central nervous system, Ann. N. Y. Acad. Sci. 757, 48-72.
2. Andrews, P. L. R. (1988). The physiology of the ferret, in: Biology and Diseases of the Ferret, Fox, J. G. (Ed.), pp. 100-134. Lea and Febiger, Philadelphia, USA.
3. Andrews, P. L. R. (1993). The mechanism of emesis induced by anti-cancer therapies, in: Emesis in Anticancer Therapy. Mechanisms and Treatment, Andrews, P. L. R. and Sanger, G. J. (Eds), pp. 111-161. Chapman and Hall, London.
4. Andrews, P. L. R. and Davidson, H. I. M. (1990). A method for the induction of emesis in the conscious ferret by abdominal vagal stimulation, J. Physiol. 422, 5.
5. Andrews, P. L. R., Rapeport, W. G. and Sanger, G. J. (1988). Neuropharmacology of emesis induced by anti-cancer therapy, Trend Pharm. Sci. 9, 334-341.
6. Andrews, P. L. R., Davis, C. J., Bingham, S., et al. (1990). The abdominal visceral innervation and the emetic reflex: pathways, pharmacology and plasticity, Can. J. Physiol. Pharmacol. 68, 325-345.
7. 3 recognition sites in the ferret area postrema, J. Pharm. Pharmacol. 40, 586-588.
8. 3) receptor-mediated depolarization of the rat isolated vagus nerve: modulation by trichloroethanol and related alcohols. Eur. J. Pharmacol. 354, 25-31.
9. Bermudez, J., Boyle, E. A., Miner, W. D., et al. (1988). The antiemetic potential of the 5-hydroxytryptamine receptor antagonist BRL43694, Br. J. Pharmac. 58, 644-650.
10. Borison, H. L. and Wang, S. C. (1953). Physiology and pharmacology of vomiting, Pharmacol. Rev. 5, 193-230.
11. Bradley, P. B., Engel, G., Feniuk, W., et al. (1986). Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine, Neuropharmacol. 25, 563-576.
12. Costall, B., Domeney, A. M., Naylor, R. J., et al. (1986). 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis, Neuropharmacol. 25, 959-961.
13. Costello, D. J. and Borison, H. L. (1977). Naloxone antagonizes narcotic self-blockade of emesis in the cat, J. Pharmacol. Exp. Ther. 203, 222-230.
14. Dey, R. D. and Hoffpsuir, J. (1984). Ultrastructural immunocytochemical localization of 5-hydroxytryptamine in gastric enterochromaffin cells, J. Histochem. Cytochem. 32, 661-666.
15. Elliot, P. and Wallis, D. I. (1990). Analysis of the actions of 5-hydroxytryptamine on the rabbit isolated vagus nerve, Naunyn-Schmiedeberg's Arch. Pharmacol. 341, 494-502.
16. Endo, T., Minami, M., Monma, Y., et al. (1990a). Effect of GR38032F on cisplatin- and cyclophosphamide-induced emesis in the ferret, Biogenic Amines 7, 525-533.
17. Endo, T., Minami, M., Monma, Y., et al. (1990b). Emesis-related biochemical and histopathological changes induced by cisplatin in the ferret, J. Toxicol. Sci. 15, 235-244.
18. 3 antagonist, on copper sulfate-induced emesis in the ferret, Biogenic Amines 8, 79-86.
19. 3 antagonist) inhibited the increase of serotonin concentration induced by cytotoxic drugs in the area postrema of ferrets, Biogenic Amines 9, 163-175.
20. Endo, T., Takahashi, M., Minami, M., et al. (1993). Effects of anticancer drugs on enzyme activities and serotonin release from ileal tissue in ferret, Biogenic Amines 9, 479-489.
21. Endo T., Nemoto M., Minami M., et al. (1995). Changes in the afferent abdominal vagal nerve activity induced by cisplatin and copper sulfate in the ferret, Biogenic Amines 11, 399-407.
22. 3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets, Res. Commun. Mol. Pathol. Pharmacol. 100, 243-253.
23. 3 receptor antagonist, on ouabain-induced emesis in ferrets, Res. Commun. Mol. Pathol. Pharmacol. 102, 227-239.
24. Erspamer, V. (1966). Occurrence of indolalkyl amines in nature, in: Handbook qf Experimental Pharmacology, Feichler, O. and Farah, A. (Eds), Vol. 19, pp. 132-181. Springer, Berlin.
25. Florczyk, A. P., Schurig, J. E. and Bradner, W. T. (1982). Cisplatin-induced emesis in the ferret: a new animal model, Cancer Treat. Rep. 66, 187-189.
26. Fox, R. A. (1992). Current status: animal models of nausea, in: Mechanisms and Control of Emesis, Colloque INSERM, vol. 223, Bianchi, A. L., Grelot, L., Miller, A. D. and King, G. I. (Eds), pp. 341-350. John Libbey Eurotext Ltd.
27. 4 receptors in copper sulfate-induced vomiting in dogs, Eur. J. Pharmacol. 257, 47-52.
28. Fukunaka, N., Sagae, S., Kudo, R., et al. (1998). Effects of granisetron and its combination with dexamethasone on cisplatin-induced delayed emesis in the ferret, Gen. Pharmacol. 31, 775-781.
29. Gandara, D. R., Harvey, W. H., Monaghan, G. G., et al. (1993). Delayed emesis following high-dose cisplatin-a double blind randomised comparative trial of ondansetron (GR-38032F) versus placebo, Eur. J. Cancer 29A(Suppl.), s35-s38.
30. 4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine, Naunyn-Schmiede Arch. Pharmacol. 347, 137-140.
31. Grunberg, S. M. and Hesketh, P. J. (1993). Control of chemotherapy induced emesis, New Engl. J. Med. 329, 1790-1796.
32. 4 receptors, Eur. J. Pharmacol. 271, 159-166.
33. Harding, R. K. (1990), Concepts and conflicts in the mechanism of emesis, Can. J. Physiol. Pharmacol. 68, 218-220.
34. Hawthorn, J., Ostler, K. J. and Andrews, P. L. R. (1988). The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cisplatin in the ferret, Quart. J. Exp. Physiol. 173, 7-21.
35. 3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret, Br. J. Pharmacol. 97, 247-255.
36. Hirafuji, M., Minami, M., Endo, T., et al. (2000). Intracellular regulatory mechanisms of 5-HT release from enterochromaffin cells in intestinal mucosa, Biogenic Amines 16, 29-52.
37. Ireland, S. J. (1987). Origin of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion and vagus nerve, Br. J. Pharmacol. 92, 407-416.
38. Kris, M. G., Tyson, L. B., Clark, R. A., et al. (1992). Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase-II study and a review of combined trials to manage delayed emesis, Cancer 70, 1012-1016.
39. Lawes, I. N. C. (1991). The central connections of area postrema define the paraventricular system involved in antinoxious behaviors, in: Nausea and Vomiting: Recent Research and Clinical Advances, Kucharczyk, J., Stewart, D. J. and Miller, A. D. (Eds), pp. 77-101. CRC Press, Boca Raton, FL.
40. Marr, H. E., Davey, P. D. and Blower, P. (1992). The effect of dexamethasone alone or in combination with granisetron, on cisplatin-induced emesis in the ferret, Br. J. Pharmacol. 104, 371.
41. McCarthy, L. E. and Borison, H. L. (1974). Respiratory mechanics of vomiting in decerebrate cats, Am. J. Physiol. 226, 738-743.
42. Miller, A. D. and Wilson, V. J. (1983a). 'Vomiting center' reanalyzed: An electrical stimulation study, Brain Res. 270, 154-158.
43. Miller, A. D. and Wilson, V. J. (1983b). Vestibular-induced vomiting after vestibulocerebellar lesions, Brain Behav. Evol. 23, 26-31.
44. Minami, M., Endo, T., Monma, Y., et al. (1991). Pharmacology of emesis induced by anti-cancer drugs, J. Toxicol. Sci. 16 (Suppl. II), 35-39.
45. Minami, M., Endo, T., Nemoto, M., et al. (1995a). How do toxic emetic stimuli cause 5-HT release in the gut and brain? in: Serotonin and the Scientific Basis of Anti-emetic Therapy, Raynold, D. J. M., Andrews, P. L. R. and Davis, C. J. (Eds), pp. 68-76. Oxford Clinical Communications, Oxford.
46. Minami, M., Saito, H. and Yoshioka, M. (1995b). Toxicological aspects of cisplatin-induced emesis with emphasis on serotonin release, J. Toxicol. Sci. 20, 77-85.
47. 4 receptor antagonist, in ferrets, Eur. J. Pharmacol. 321, 333-342.
48. Minami, M., Endo, T., Hirafuji, M., et al. (2003). Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity, Pharmacol. Ther. 99, 149-165.
49. Miner, W. D. and Sanger, G. J. (1986). Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism, Br. J. Pharmacol. 88, 497-499.
50. 4 receptors, Res. Commun. Mol. Pathol. Pharmacol. 109, 217-230.
51. Newberry, N. R., Watkins, C. J., Reynolds, D. J., et al. (1992). Pharmacology of the 5-hydroxytryptamin-induced depolarization of the ferret vagus nerve in vitro, Eur. J. Pharmacol. 221, 157-160.
52. Newson, B., Ahlman, H., Dahlström, A., et al. (1982). Ultrastructural observations in the rat ileal mucosa of possible epithelial 'taste cells' and submucosal sensory neurons, Acta Physiol. Scand. 114, 161-164.
53. Nilsson, O., Ericson, L. E., Dahlström, A., et al. (1985). Subcellular localization of serotonin immunoreactivity in rat enterochromaffin cells, Histochemistry 82, 351-355.
54. Ossenkopp, K.-P. and Ossenkopp, M. D. (1985). Animal models of motion sickness: Are nonemetric species an appropriate choice? The Physiologist 28, s61-s62.
55. 3 receptors, in: Serotonin and the Scientific Basis of Anti-emetic Therapy, Raynold, D. J. M., Andrews, P. L. R. and Davis, C. J. (Eds), pp. 95-105. Oxford Clinical Communications, Oxford.
56. Prestayko, A. W., D'Aoust, J. C., Issell, B. F., et al. (1979). Cisplatin (cis-diamminedichloroplatinum II), Cancer Treat. Rev. 6, 17-39.
57. Racké, K., Schwörer, H. and Kilringer, H. (1988). Adrenergic modulation of the release of 5-hydroxytryptamine from the vascularly perfused ileum of the guinea-pig, Br. J. Pharmacol. 95, 923-931.
58. Rath, U., Upadhyaya, B. K., Arechavala, E., et al. (1993). Role of ondansetron plus dexamethasone in fractionated chemotherapy, Oncology 50, 168-172.
59. Roila, F. (1993).,Ondansetron plus dexamethasone compared to the standard metocloplamide combination, Oncology 50, 163-167.
60. Rosenberg, B., VanCamp, L., Trosko, J. E., et al. (1969). Platinum compounds: a new class of potent antitumour agents, Nature 222, 385-386.
61. Rudd, J. A., Costall, B., Naylor, R. J., et al. (1990). The emetic action of copper sulfate in the ferret, Eur. J. Pharmacol. 183, 1213.
62. 3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret, Neuropharmacology 33, 1607-1608.
63. 3 receptor antagonist, GR38032F, Cancer Treat Rev. 14, 333-336.
64. Stewart, D. J. (1991). Nausea and vomiting in cancer patients, in: Nausea and vomiting: Recent research and clinical advances, Kucharczyk, J., Stewart, D. J. and Miller, A. D. (Eds), pp. 177-203. CRC Press, Boca Raton FL.
65. 4 receptor agonist on abdominal afferent nerve activity in rats (abstract), Jpn. J. Pharmacol. 71 (Suppl. 1), 245.
66. 4 receptor involvement in emesis, in: Serotonin and the Scientific Basis of Anti-emetic Therapy, Raynold, D. J. M., Andrews, P. L. R. and Davis, C. J. (Eds), pp. 192-199. Oxford Clinical Communications, Oxford.
67. Yao, Z., Adler, A., Kovar, P., et al. (1992). A restraint device for blood sampling and direct blood pressure measurement in conscious ferrets, Contemporary Topics of the American Association for Laboratory Animal Sciences 31, 19-21.
68. Yoshioka, M., Ikeda, M., Abe, H., et al. (1992). Pharmacological characterization of 5-hydroxytryptamine-induced excitation of afferent cervical vagus nerve in anesthetized rats, Br. J. Pharmacol. 106, 544-549.
69. Wang, S. C. and Borrison, H. L. (1951). Copper sulfate emesis: a study of afferent pathways from the gastrointestinal tract, Am. J. Physiol. 164, 520-526.
70. Wetchler, B. V. (1991). Outpatient anesthesia: What are the problems in the recovery room? Can. J. Anesth. 38, 890-894.